Condition
Drug Abuse, Intravenous
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05794984CompletedPrimary
Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece
NCT05679284RecruitingPrimary
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
NCT03106194Not ApplicableCompletedPrimary
Case Management in HCV Infected PWID
NCT02363517Phase 3Unknown
The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach
Showing all 4 trials